![](/images/graphics-bg.png)
Atropine 0.01% for the Control of Myopia in Chinese Children: Effect on Accommodation Functions and Pupil Size
Joint Authors
Qu, Xiaomei
Wang, Yuliang
Yao, Jing
Source
Issue
Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-8, 8 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2020-02-26
Country of Publication
Egypt
No. of Pages
8
Main Subjects
Abstract EN
Background.
To explore the effect of atropine 0.01% on accommodation functions and pupil size for safely and effectively controlling myopia in Chinese children.
Methods.
This was a single-center randomized clinical trial.
63 participants with myopia of at least −0.50 D and astigmatism of ≤−2.50 D were enrolled and randomized to receive atropine 0.01% once nightly with regular single-vision lenses or to wear regular single-vision lenses, in an allocation ratio of 3 : 2.
Primary outcomes included changes of accommodation functions, pupil diameter, distant and near best-corrected visual acuity (BCVA), near stereoacuity, and intraocular pressure (IOP).
Secondary outcome was myopic progression at 6 months.
Results.
61 participants completed the follow-up.
Compared with the control group, the atropine-treated children showed a statistically significant increase in pupil diameter after 6 months (0.7 ± 0.7 vs.
0.1 ± 0.5 mm, P=0.01).
Despite the enlarged pupil, routine vision-related activities were not affected.
The mean changes in accommodative functions, BCVA, near stereoacuity, and IOP, did not differ significantly between the groups.
At 6 months, participants in the control group showed greater myopia progression than those in the atropine group (spherical equivalent: −0.60 ± 0.43 vs.−0.30 ± 0.42 D, P<0.001; axial length: 0.35 ± 0.20 vs.
0.24 ± 0.16 mm, P=0.001).
Conclusions.
Atropine 0.01% eye drops significantly increased pupil diameter less than one mm, but it did not affect accommodative functions, BCVA, near stereoacuity, and IOP.
Combined with its reducing myopia progression, atropine 0.01% can be used as a safe and effective treatment for myopia in Chinese children.
American Psychological Association (APA)
Wang, Yuliang& Yao, Jing& Qu, Xiaomei. 2020. Atropine 0.01% for the Control of Myopia in Chinese Children: Effect on Accommodation Functions and Pupil Size. Journal of Ophthalmology،Vol. 2020, no. 2020, pp.1-8.
https://search.emarefa.net/detail/BIM-1189678
Modern Language Association (MLA)
Wang, Yuliang…[et al.]. Atropine 0.01% for the Control of Myopia in Chinese Children: Effect on Accommodation Functions and Pupil Size. Journal of Ophthalmology No. 2020 (2020), pp.1-8.
https://search.emarefa.net/detail/BIM-1189678
American Medical Association (AMA)
Wang, Yuliang& Yao, Jing& Qu, Xiaomei. Atropine 0.01% for the Control of Myopia in Chinese Children: Effect on Accommodation Functions and Pupil Size. Journal of Ophthalmology. 2020. Vol. 2020, no. 2020, pp.1-8.
https://search.emarefa.net/detail/BIM-1189678
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1189678